1. Home
  2. BANL vs CLRB Comparison

BANL vs CLRB Comparison

Compare BANL & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

HOLD

Current Price

$15.62

Market Cap

28.5M

Sector

Energy

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.53

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANL
CLRB
Founded
2015
2002
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
24.5M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
BANL
CLRB
Price
$15.62
$2.53
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
199.9K
31.5K
Earning Date
04-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$2.20
52 Week High
$14.35
$6.52

Technical Indicators

Market Signals
Indicator
BANL
CLRB
Relative Strength Index (RSI) 75.53 47.65
Support Level $0.36 $2.44
Resistance Level N/A $2.70
Average True Range (ATR) 1.94 0.10
MACD 0.25 -0.00
Stochastic Oscillator 88.97 36.00

Price Performance

Historical Comparison
BANL
CLRB

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: